An occurrence of acute localised myelitis was recently seen in four adult patients with atopic dermatitis who had hyperIgEaemia and mite antigen specific IgE. The total and mite antigen specific IgE was therefore studied in serum samples from 19 consecutive patients with acute localised myelitis of unknown aetiology, 56 patients with clinically definite multiple sclerosis, and 40 healthy controls. The total IgE concentration was significantly higher in acute localised myelitis (median=360 U/ml) than in multiple sclerosis (median=52 U/ml, p<0.0001) and the controls (median=85 U/ml, p=0.0002). The specific IgE to Dermatophagoides pteronyssinus was found more often in patients with acute localised myelitis (95%) than in patients with multiple sclerosis (34%, p<0.0001) and the controls (35%, p<0.0001) and the specific IgE to Dermatophagoides farinae was similar (acute localised myelitis 79%, multiple sclerosis 29% (p<0.0001), controls 30%, (p=0.0003). Atopic dermatitis coexisted more commonly in patients with acute localised myelitis (37%) than in patients with multiple sclerosis (0%, p<0.0001) and the controls (7.5%, p=0.0089). Therefore, acute localised myelitis with hyperIgEaemia, in which atopy to mite antigens seems to exist, may be a distinct subtype of allergic myelitis—that is, atopic myelitis.
- mite antigen specificity
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Atopy is defined as an enhanced IgE responsiveness to such common environmental antigens as pollens, foods, and house dust mites.1 Atopic disorders are common in childhood, and the number of adult patients with atopic disorders is now increasing in many industrialised countries.2 Although neither atopic disorders nor hyperIgEemia have previously been shown to be associated with myelitis, we recently found four adult patients with acute myelitis who all had hyperIgEaemia and mite antigen specific IgE as well as atopic dermatitis.3 The existence of such patients prompted us to study the total and mite antigen specific IgE in acute myelitis.
Subjects and methods
Nineteen consecutive patients, who showed an acute onset of monophasic spinal cord syndrome which was well defined rostrally (acute localised myelitis) and were subjected to a thorough neurological examination and routine laboratory tests between July 1992 and June 1997, were enrolled in the present study. No specific cause was identified in any. None of the patients developed a clear cut relapse during the follow up period (mean (SD) 23 (SD 19) months). Patients with acute disseminated encephalomyelitis, who clinically showed disseminated or multiple involvement of the CNS in addition to that of the spinal cord, were excluded. As controls, 56 patients with clinically definite multiple sclerosis,4 who were followed up at our multiple sclerosis clinic during the same period, were used. In addition, 40 healthy hospital workers, 20 men and 20 women, were used as controls. The disability of the patients was evaluated using the Kurtzke’s expanded disability status scale (EDSS).5The age at examination was 34 (SD 12) years in the patients with acute localised myelitis, 41 (SD 11) years in the patients with multiple sclerosis, and 34 (SD 8) years in the controls. None of the subjects had anti-HTLV-I antibody.
ASSAY FOR TOTAL AND MITE ANTIGEN SPECIFIC IgE
The total and allergen specific IgE in the serum were measured by an enzyme linked immunosorbent assay (ELISA).3 Two mite antigens, Dermatophagoides farinae andDermatophagoides pteronyssinus, cedar pollen, candida, egg white, milk, wheat, rice, and soybean were used as allergens for ELISA (AlaSTAT, Sankojunyaku, Tokyo, Japan). The total and mite antigen specific IgE were measured in all subjects, and the specific IgE to other allergens was measured in hyperIgEaemic patients with acute localised myelitis. The patients with a serum IgE concentration>250 U/ml were considered to have hyperIgEaemia according to the preliminary control study.3 The cut off value for allergen specific IgE was 0.34 IU/ml.3
The Mann-Whitney U test was used for a statistical analysis of the total serum IgE concentration. Either the χ2 test or Fisher’s exact test (when the criteria of the χ2 test was not fulfilled) was used for the analysis of the frequency of hyperIgEaemia, specific IgE to mite antigens, and other clinical-laboratory abnormalities.
TOTAL AND ALLERGEN SPECIFIC IgE
The serum total IgE concentration was significantly higher in the patients with acute localised myelitis (median=360 U/ml) than in those with multiple sclerosis (median=52 U/ml, p<0.0001) and in the healthy controls (median=85 U/ml, p=0.0002). The frequency of hyperIgEaemia was also significantly higher in the patients with acute localised myelitis (63%) than in those with multiple sclerosis (18%, p=0.0001) and in the healthy controls (23%, p=0.0025). Moreover, the patients with acute localised myelitis also showed a significantly higher frequency of mite antigen specific IgE than did those with multiple sclerosis (D pteronyssinus, 95% v 34%, p<0.0001, andD farinae, 79% v 29%, p<0.0001) and the healthy controls (D pteronyssinus, 95% v35%, p<0.0001, and D farinae, 79% v 30%, p=0.0003). Atopic dermatitis more commonly coexisted at the time of neurological examination in the patients with acute localised myelitis (37%) than in either the patients with multiple sclerosis (0%, p<0.0001) or the healthy controls (7.5%, p=0.0089), whereas the frequency of coexisting allergic rhinitis and asthma did not differ significantly among the three groups (16% and 0% in patients with acute localised myelitis, 11% and 0% in the patients with multiple sclerosis, and 23% and 2.5% in the controls). There was no significant difference between patients with multiple sclerosis and the controls for total serum IgE concentration, the frequency of mite antigen specific IgE and atopic dermatitis. In the 12 hyperIgEaemic patients with acute localised myelitis, all had specific IgE to D pteronyssinus and 11 had specific IgE to D farinae, whereas specific IgE to other common environmental antigens was found at much lower frequencies (five to cedar pollen, three to soybean, two to candida, wheat, and rice, and one to egg white and milk).
The clinical-laboratory findings were compared between the acute localised myelitis patients with and without hyperIgEamia (table). The frequency of atopic dermatitis was significantly higher in the hyperIgEaemic patients than in the normoIgEaemic patients (p=0.0174). The frequency of female patients was higher in the hyperIgEaemic patients than in the normoIgEaemic patients (42% v 14%), but the difference did not reach significance, probably due to the small sample size. The age of onset, initial symptoms, symptoms and signs during illness, and the EDSS scores did not differ significantly between the two groups. However, in hyperIgEaemic patients, the cervical cord was three times more commonly affected than the thoracic cord, whereas in normoIgEaemic patients the thoracic cord was affected more often than the cervical cord.
The frequency of CSF pleocytosis was significantly lower in hyperIgEaemic patients than in normoIgEaemic patients (17%v 71%, p=0.0449). The increase in total protein was also found less often in hyperIgEaemic patients than in normoIgEaemic patients (8% v 43%), although this difference did not reach significance. None of the nine hyperIgEaemic patients examined showed either oligoclonal IgG bands or an increased IgG index.
Among the hyperIgEaemic patients who showed a high signal intensity lesion on T2 weighted images of the spinal cord, the lesion was located in the high cervical cord (C2–4) in all but one case (figure), whereas no such predilection to the high cervical cord was seen in the normoIgEaemic patients. The MRI lesions persisted for more than three months in four hyperIgEaemic patients (4, 13, 16, and 25 months), despite the benign clinical course. Only one of 10 hyperIgEaemic patients examined had subclinical lesions on brain MRI (several small lesions in the white matter).
In the present study, a significant association of acute localised myelitis with both hyperIgEaemia and specific IgE antibody to mite antigens was found. An examination of specific IgE to other common allergens disclosed two mite antigens to be the main antigens for IgE responses in these patients. Moreover, hyperIgEaemic patients with acute localised myelitis showed the following distinct features: (1) a preferential involvement of the cervical cord, which was less often affected in the normoIgEaemic acute localised myelitis patients as well as in cases of acute transverse myelitis in the previous report,6 (2) a frequent coexistence of atopic dermatitis, (3) a high frequency of normal CSF findings including a normal IgG index and the absence of oligoclonal IgG bands, and (4) spot-like high signal intensity lesions preferentially affecting the high cervical cord on the spinal cord MRI.
Together with the clinical course, both the absence of an abnormal IgG response in CSF and rare brain lesions on MRI probably rule out the possibility of multiple sclerosis in our hyperIgEaemic patients. Furthermore, our study disclosed that neither the total serum IgE nor the frequency of mite antigen specific IgE increased in multiple sclerosis, which is consistent with the previous findings in white patients with multiple sclerosis.7 8 These findings thus suggest that acute localised myelitis with hyperIgEaemia might have been produced by an immunological mechanism distinct from multiple sclerosis.
In atopic disorders, both IgE and mast cells are known to play a central part.1 9 10 The binding of allergens to mast cell bound IgE initiates the release of inflammatory mediators, which results in inflammation and the characteristic symptoms of atopic disorders.11 If mite antigen specific IgE antibodies possess some cross reactivity with CNS antigens, they may well initiate the breakdown of the blood-brain barrier through the binding between mast cells and the CNS antigens, as suggested in the case of IgE antibody to myelin basic protein in experimental allergic encephalomyelitis.11 Interestingly, both cutaneous mast cells and CNS mast cells are connective tissue type mast cells,12 whereas mucosal type mast cells exist in other sites affected by atopic disorders. The frequent coexistence of atopic dermatitis in our patients may therefore suggest an involvement of connective tissue type mast cells commonly present in the two target tissues—skin and the CNS.
Finally, we consider it important to recognise atopy to mite antigens as one of the potential causes of myelitis. Because acute localised myelitis with hyperIgEaemia has distinct features and atopy to mite antigens is considered to be one of the underlying factors of this condition, we propose the diagnostic term atopic myelitis for such patients.
This work was supported in part by grants from the Neuroimmunological Disease Research Committee, the Ministry of Health and Welfare of Japan, and from the Ministry of Education, Science, Sports and Culture of Japan (No 08670712).